title: Re: Zinc supplement use and risk of prostate cancer.
authors.forename: Ellen T
authors.initials: ET
authors.lastname: Chang
authors.forename: Maria
authors.initials: M
authors.lastname: Hedelin
authors.forename: Hans-Olov
authors.initials: HO
authors.lastname: Adami
authors.forename: Henrik
authors.initials: H
authors.lastname: Grönberg
authors.forename: Katarina A
authors.initials: KA
authors.lastname: Bälter
mesh_terms: D002273:Carcinogens / Q000008:administration & dosage / Q000009:adverse effects; D019587:Dietary Supplements / Q000009:adverse effects; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000139:chemically induced / Q000517:prevention & control; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D017967:Zinc Compounds / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D002273:Carcinogens; D017967:Zinc Compounds